What is QNCX's dilution risk score?

QNCX has a latest available DilutionScore record of 32/100, categorized as medium dilution risk by the DilutionWatch scoring model. DilutionWatch displays SEC filing and dilution indicators for QNCX, including shelf registrations, ATM offerings, warrant exercises, PIPE deals, and reverse split signals when detected in source data.

What SEC filings does DilutionWatch track for QNCX?

DilutionWatch tracks 25 SEC filing types for QNCX including S-3 shelf registrations, 424B prospectuses (ATM offerings), S-1 registration statements, 8-K material events, warrant exercise notices, convertible note agreements, and Form 4 insider transactions. Alerts are delivered via email within minutes of a filing appearing on EDGAR.

How does stock dilution affect QNCX shareholders?

Stock dilution occurs when a company issues new shares, reducing the ownership percentage of existing shareholders. For QNCX, common dilution events include at-the-market (ATM) stock offerings, shelf registration drawdowns, warrant exercises, and convertible note conversions. Each event increases the share count and can pressure the stock price lower.

Is DilutionWatch free for QNCX tracking?

DilutionWatch provides a free tier that shows DilutionScores and basic filing history for QNCX. Premium plans ($19.95/month Basic, $39.95/month Premium) unlock real-time email alerts, the full Pulse™ feed, advanced dilution forecasts, and access to all 10,000+ tracked tickers.

QNCX Dilution Risk Score: 32/100 (MEDIUM)

Score Breakdown

📋 Offering Ability

60

💰 Cash Runway

0

📊 Float Risk

7

⚠️ Warrant Exposure

15

🔄 Convertible Debt

40

Dilution Forecast

⛅

Watch

Minor dilution signals detected

model est. 15%

🔄 Reverse Split model est. 30%

• 50-day avg $1.19 approaching $1 threshold

🔔 Track QNCX — Get forecast alerts →

Market Data

Market Cap$22.49M

Shares Outstanding16.30M

Float15.71M

Cash$115.98M

DebtN/A

Short InterestN/A

Institutional Holdings

10 institutional holders · 14.18M shares

#1 Nantahala Capital Management, LLC 2.67M shares

#2 Adage Capital Partners GP L.L.C. 2.25M shares

#3 Vanguard Group Inc 2.08M shares

+ 7 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest56.6K

Days to Cover1.5

% of Float0.4%

FINRA data as of Jul 31, 2026

Insider Buy/Sell Ratio

Recent SEC Activity

xbrl XBRL WARRANT 2025-12-31

xbrl XBRL CONVERTIBLE 2019-12-31

4 INSIDER TRANSACTION 2026-01-23

Full SEC filing analysis available with free account →

Recent News

No recent news

Factual QNCX Dilution Snapshot

Quince Therapeutics, Inc. (QNCX) has a DilutionScore of 32/100, rated Medium dilution risk. Score date: August 28, 2026.

Recent SEC activity tracked for QNCX: 4 on 2026-01-23; 4 on 2026-01-23; 4 on 2026-01-23.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.